Bazelet Group News
2 articles
growth-positive
Ayurcann Expansion Continues with New Joint Venture with Largest Medical Cannabis Company in Israel
Ayurcann Holdings Corp. has entered into a joint venture agreement with Bazelet Nehushtan Ltd. and/or Bazelet Development and Technologies Ltd. to manufacture proprietary products for the Canadian market. Bazelet is a licensed medical cannabis processor based in Israel and one of the largest medical cannabis companies in the country. The joint venture agreement allows Ayurcann to be the Canadian manufacturer of all Bazelet products. This partnership is expected to introduce unique products into the Canadian marketplace and provide opportunities for continuous product introductions. Ayurcann is focused on expanding its domestic operations and seeking new market possibilities and partnerships to grow in the cannabis industry.
PartnersExpand
growth-positive
Bazelet launches first-of-the kind, proprietary, terpene-enriched medical cannabis oils specially designed for medical needs such as women health, pain treatment, improved sleep and special needs of the elderly population
Bazelet, the largest medical company in Israel, has launched multiple lines of terpene-enriched cannabis oils designed for various indications and personal needs. The company has developed a unique way of formulating medical cannabis oils by controlling their terpene content. Bazelets oils have a higher terpene content than common cannabis oils and are referred to as terpenes-enriched. The company has filed patent applications to protect its terpene-enriched formulations. Bazelet also offers patent-protected terpene blends to be added to extracts produced in other geographies. The technology has the potential for growth and positive impact on the company.
Customers
